Clinical Trial Update: Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II [Phase 3]

View source ↗

Summary

Phase 3 trial update examining clopidogrel with aspirin in high-risk acute non-disabling cerebrovascular events has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Clopidogrel with Aspirin (clopidogrel and aspirin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke, Transient Ischemic Attack | Phase 3 | Status: COMPLETED